Monte Rosa Therapeutics, Inc. GLUE
NASDAQ · United States · Health Technology
$10.45-0.81 (-7.21%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.43 | -0.38 | -13.0% | $9.00M | -30.3% | +1.7%$15.61→$15.88 |
| Q1 2026 | 2026-05-07 | -0.45 | -0.28 | -60.7% | — | — | -4.9%$20.39→$19.39 |
| Q4 2025 | 2026-03-17 | -0.55 | -0.34 | -61.8% | — | — | -3.6%$16.35→$15.76 |
| Q3 2025 | 2025-11-06 | -0.33 | -0.39 | +15.4% | — | — | 0.0%$12.31→$12.31 |
| Q4 2024 | 2025-03-20 | 0.27 | 0.03 | +800.0% | — | — | — |
| Q4 2023 | 2024-03-14 | -0.58 | -0.39 | -48.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.